• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
?
-

Resources for You

NovoSevenRT

STN: BL 103665
Proper Name: Coagulation Factor VIIa (Recombinant)
Tradename: NovoSevenRT
Manufacturer: Novo Nordisk Inc, License #1261

Indication:

  • Treatment of bleeding episodes in hemophilia A or B with inhibitors and in acquired hemophilia (1.1)
  • Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors and in acquired hemophilia (1.2)
  • Treatment of bleeding episodes in congenital FVII deficiency (1.3)
  • Prevention of bleeding in surgical interventions or invasive procedures in congenital FVII deficiency (1.4)
-

Supporting Documents

-
-

Related Information

-
 

Contact FDA

(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

1401 Rockville Pike

Suite 200N/HFM-47

Rockville, MD 20852-1448